Perspective Therapeutics (CATX) Enterprise Value Growth (5y) (2015 - 2026)
Perspective Therapeutics (CATX) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Perspective Therapeutics | 303.56 Mn | 303.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.72% |
| Dec 31, 2025 | -72.11% |
| Sep 30, 2025 | -145.82% |
| Jun 30, 2025 | -171.72% |
| Mar 31, 2025 | -175.11% |
| Dec 31, 2024 | -134.79% |
| Sep 30, 2024 | -132.26% |
| Jun 30, 2024 | -122.87% |
| Mar 31, 2024 | -95.09% |
| Dec 31, 2023 | -3.26% |
| Sep 30, 2023 | -14.36% |
| Jun 30, 2023 | -52.58% |
| Mar 31, 2023 | -51.85% |
| Dec 31, 2022 | -50.45% |
| Sep 30, 2022 | -49.46% |
| Jun 30, 2022 | -44.18% |
| Mar 31, 2022 | -41.44% |
| Dec 31, 2021 | -38.26% |
| Sep 30, 2021 | -35.10% |
| Jun 30, 2021 | -38.81% |